Hap Trading, LLC Cti Biopharma Corp Call Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$3.55 - $6.27 $18,105 - $31,976	-5,100 Reduced 26.84%	13,900 $27,000
Q1 2022 May 12, 2022	SELL	$1.9 - $5.23 $3,420 - $9,414	-1,800 Reduced 8.65%	19,000 $18,000
Q4 2021 Feb 14, 2022	BUY	$1.44 - $2.86 $10,080 - $20,020	7,000 Added 50.72%	20,800 $11,000
Q3 2021 Nov 10, 2021	BUY	$2.25 - $3.18 $31,050 - $43,884	13,800 New	13,800 $7,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.